Small interfering RNA against transcription factor STAT6 inhibits allergic airway inflammation and hyperreactivity in mice 1

Journal of Immunology

Volumn 182, Issue 12, 2009, Pages 7501-7508

  Darcan Nicolaisen, Yasemin ^a   Meinicke, Holger ^a   Fels, Gabriele ^a   Hegend, Olga ^a   Haberland, Annekathrin ^a   Kühl, Anja ^a   Loddenkemper, Christoph ^a   Witzenrath, Martin ^a   Kube, Stefanie ^a   Henke, Wolfgang ^a   Hamelmann, Eckard ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; MESSENGER RNA; SMALL INTERFERING RNA; STAT1 PROTEIN; STAT2 PROTEIN; STAT5A PROTEIN; STAT6 PROTEIN; BETA CHEMOKINE;

ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; BRONCHITIS; CD4+ T LYMPHOCYTE; CELL HYPERPLASIA; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EOSINOPHIL; FEMALE; GOBLET CELL; HELA CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; IN VIVO STUDY; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BAGG ALBINO MOUSE; BRONCHUS HYPERREACTIVITY; CELL LINE; GENE EXPRESSION REGULATION; GENETICS; HYPERSENSITIVITY; IMMUNOLOGY; METABOLISM; PATHOLOGY; SECRETION;

ANIMALS; BRONCHIAL HYPERREACTIVITY; CELL LINE; CHEMOKINES, CC; FEMALE; GENE EXPRESSION REGULATION; HUMANS; HYPERSENSITIVITY; INTERLEUKIN-13; INTERLEUKIN-4; INTERLEUKIN-5; MICE; MICE, INBRED BALB C; RNA, MESSENGER; RNA, SMALL INTERFERING; STAT6 TRANSCRIPTION FACTOR;

EID: 67649232613     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0713433     Document Type: Article

References (50)

1. Hou, J., U. Schindler, W. J. Henzel, T. C. Ho, M. Brasseur, and S. L. McKnight. 1994. An interleukin-4-induced transcription factor: IL-4 Stat. Science 265: 1701-1706. (Pubitemid 24314900)
2. Quelle, F. W., K. Shimoda, W. Thierfelder, C. Fischer, A. Kim, S. M. Ruben, J. L. Cleveland, J. H. Pierce, A. D. Keegan, and K. Nelms. 1995. Cloning of murine Stat6 and human Stat6, Stat proteins that are tyrosine phosphorylated in responses to IL-4 and IL-3 but are not required for mitogenesis. Mol. Cell. Biol. 15: 3336-3343.
3. Ortmann, R. A., T. Cheng, R. Visconti, D. M. Frucht, and J. J. O'Shea. 2000. Janus kinases and signal transducers and activators of transcription: their roles in cytokine signaling, development and immunoregulation. Arthritis Res. 2: 16-32.
4. Takeda, K., T. Tanaka, W. Shi, M. Matsumoto, M. Minami, S. Kashiwamura, K. Nakanishi, N. Yoshida, T. Kishimoto, and S. Akira. 1996. Essential role of Stat6 in IL-4 signalling. Nature 380: 627-630.
5. Christodoulopoulos, P., L. Cameron, Y. Nakamura, C. Lemiere, S. Muro, M. Dugas, L. P. Boulet, M. Laviolette, R. Olivenstein, and Q. Hamid. 2001. TH2 cytokine-associated transcription factors in atopic and nonatopic asthma: evidence for differential signal transducer and activator of transcription 6 expression. J. Allergy Clin. Immunol. 107: 586-591.
6. Shimoda, K., J. van Deursen, M. Y. Sangster, S. R. Sarawar, R. T. Carson, R. A. Tripp, C. Chu, F. W. Quelle, T. Nosaka, D. A. Vignali, et al. 1996. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 380: 630-633.
7. Tomkinson, A., A. Kanehiro, N. Rabinovitch, A. Joetham, G. Cieslewicz, and E. W. Gelfand. 1999. The failure of STAT6-deficient mice to develop airway eosinophilia and airway hyperresponsiveness is overcome by interleukin-5. Am. J. Respir. Crit. Care Med. 160: 1283-1291. (Pubitemid 29487472)
8. Napoli, C., C. Lemieux, and R. Jorgensen. 1990. Introduction of a chimeric chalcone synthase gene into petunia results in reversible co-suppression of homologous genes in trans. Plant Cell 2: 279-289. (Pubitemid 120029588)
9. van Der Krol, A. R., L. A. Mur, M. Beld, J. N. Mol, and A. R. Stuitje. 1990. Flavonoid genes in petunia: addition of a limited number of gene copies may lead to a suppression of gene expression. Plant Cell 2: 291-299.
10. Fire, A., S. Xu, M. K. Montgomery, S. A. Kostas, S. E. Driver, and C. C. Mello. 1998. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391: 806-811. (Pubitemid 28099681)
11. Bitko, V., A. Musiyenko, O. Shulyayeva, and S. Barik. 2005. Inhibition of respiratory viruses by nasally administered siRNA. Nat. Med. 11: 50-55.
12. Finotto, S., G. T. De Sanctis, H. A. Lehr, U. Herz, M. Buerke, M. Schipp, B. Bartsch, R. Atreya, E. Schmitt, P. R. Galle, et al. 2001. Treatment of allergic airway inflammation and hyperresponsiveness by antisense-induced local blockade of GATA-3 expression. J. Exp. Med. 193: 1247-1260.
13. Hamelmann, E., J. Schwarze, K. Takeda, A. Oshiba, G. L. Larsen, C. G. Irvin, and E. W. Gelfand. 1997. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am. J. Respir. Crit. Care Med. 156: 766-775.
14. Held, H. D., C. Martin, and S. Uhlig. 1999. Characterization of airway and vascular responses in murine lungs. Br. J. Pharmacol. 126: 1191-1199.
15. Witzenrath, M., B. Ahrens, S. M. Kube, A. Braun, H. G. Hoymann, A. C. Hocke, S. Rosseau, N. Suttorp, E. Hamelmann, and H. Schutte. 2006. Detection of allergen-induced airway hyperresponsiveness in isolated mouse lungs. Am. J. Physiol. 291: L466-L472.
16. Held, H. D., and S. Uhlig. 2000. Basal lung mechanics and airway and pulmonary vascular responsiveness in different inbred mouse strains. J. Appl. Physiol. 88: 2192-2198.
17. Darcan, Y., A. Petersen, W. M. Becker, J. Galle, M. Ernst, J. Ahmed, and U. Seitzer. 2005. Immunoprophylaxis with DNA vaccination inhibits Th2-mediated responses and airway inflammation in mice sensitised with the major timothy grass pollen allergen Phl p 5b. Vaccine 23: 4203-4211.
18. Corry, D. B., G. Grunig, H. Hadeiba, V. P. Kurup, M. L. Warnock, D. Sheppard, D. M. Rennick, and R. M. Locksley. 1998. Requirements for allergen-induced airway hyperreactivity in T and B cell-deficient mice. Mol. Med. 4: 344-355.
19. Wills-Karp, M., J. Luyimbazi, X. Xu, B. Schofield, T. Y. Neben, C. L. Karp, and D. D. Donaldson. 1998. Interleukin-13: central mediator of allergic asthma. Science 282: 2258-2261.
20. Finkelman, F. D., I. M. Katona, J. F. Urban, Jr., J. Holmes, J. Ohara, A. S. Tung, J. V. Sample, and W. E. Paul. 1988. IL-4 is required to generate and sustain in vivo IgE responses. J. Immunol. 141: 2335-2341.
21. Nilsson, G., and K. Nilsson. 1995. Effects of interleukin (IL)-13 on immediate-early response gene expression, phenotype and differentiation of human mast cells: comparison with IL-4. Eur. J. Immunol. 25: 870-873.
22. Kaplan, M. H., U. Schindler, S. T. Smiley, and M. J. Grusby. 1996. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 4: 313-319.
23. Kuperman, D., B. Schofield, M. Wills-Karp, and M. J. Grusby. 1998. Signal transducer and activator of transcription factor 6 (Stat6)-deficient mice are protected from antigen-induced airway hyperresponsiveness and mucus production. J. Exp. Med. 187: 939-948.
24. Akimoto, T., F. Numata, M. Tamura, Y. Takata, N. Higashida, T. Takashi, K. Takeda, and S. Akira. 1998. Abrogation of bronchial eosinophilic inflammation and airway hyperreactivity in signal transducers and activators of transcription (STAT)6-deficient mice. J. Exp. Med. 187: 1537-1542.
25. Quarcoo, D., S. Weixler, D. Groneberg, R. Joachim, B. Ahrens, A. H. Wagner, M. Hecker, and E. Hamelmann. 2004. Inhibition of signal transducer and activator of transcription 1 attenuates allergen-induced airway inflammation and hyperreactivity. J. Allergy Clin. Immunol. 114: 288-295.
26. McCusker, C. T., Y. Wang, J. Shan, M. W. Kinyanjui, A. Villeneuve, H. Michael, and E. D. Fixman. 2007. Inhibition of experimental allergic airways disease by local application of a cell-penetrating dominant-negative STAT-6 peptide. J. Immunol. 179: 2556-2564.
27. Bertrand, J. R., M. Pottier, A. Vekris, P. Opolon, A. Maksimenko, and C. Malvy. 2002. Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivo. Biochem. Biophys. Res. Commun. 296: 1000-1004.
28. Pai, S. I., Y. Y. Lin, B. Macaes, A. Meneshian, C. F. Hung, and T. C. Wu. 2006. Prospects of RNA interference therapy for cancer. Gene Ther. 13: 464-477.
29. Lu, P. Y., F. Y. Xie, and M. C. Woodle. 2003. siRNA-mediated antitumorigenesis for drug target validation and therapeutics. Curr. Opin. Mol. Ther. 5: 225-234. (Pubitemid 37185340)
30. Reich, S. J., J. Fosnot, A. Kuroki, W. Tang, X. Yang, A. M. Maguire, J. Bennett, and M. J. Tolentino. 2003. Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model. Mol. Vis. 9: 210-216.
31. Dykxhoorn, D. M., and J. Lieberman. 2006. Silencing viral infection. PLoS Med. 3: e242.
32. Check, E. 2005. A crucial test. Nat. Med. 11: 243-244.
33. McFarland, T. J., Y. Zhang, B. Appukuttan, and J. T. Stout. 2004. Gene therapy for proliferative ocular diseases. Expert Opin. Biol. Ther. 4: 1053-1058.
34. Zhang, W., H. Yang, X. Kong, S. Mohapatra, H. San Juan-Vergara, G. Hellermann, S. Behera, R. Singam, R. F. Lockey, and S. S. Mohapatra. 2005. Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene. Nat. Med. 11: 56-62.
35. Rossi, J. J. 2006. RNAi as a treatment for HIV-1 infection. BioTechniques Suppl: 25-29.
36. Raoul, C., S. D. Barker, and P. Aebischer. 2006. Viral-based modelling and correction of neurodegenerative diseases by RNA interference. Gene Ther. 13: 487-495.
37. Wood, M. J., B. Trulzsch, A. Abdelgany, and D. Beeson. 2003. Therapeutic gene silencing in the nervous system. Hum. Mol. Genet. 12(Spec. No. 2): R279-R284. (Pubitemid 37259343)
38. Teran, L. M., M. Mochizuki, J. Bartels, E. L. Valencia, T. Nakajima, K. Hirai, and J. M. Schroder. 1999. Th1- and Th2-type cytokines regulate the expression and production of eotaxin and RANTES by human lung fibroblasts. Am. J. Respir. Cell. Mol. Biol. 20: 777-786.
39. Zhang, X., P. Shan, D. Jiang, P. W. Noble, N. G. Abraham, A. Kappas, and P. J. Lee. 2004. Small interfering RNA targeting heme oxygenase-1 enhances ischemia-reperfusion-induced lung apoptosis. J. Biol. Chem. 279: 10677-10684.
40. Chien, P. Y., J. Wang, D. Carbonaro, S. Lei, B. Miller, S. Sheikh, S. M. Ali, M. U. Ahmad, and I. Ahmad. 2005. Novel cationic cardiolipin analogue-based liposome for efficient DNA and small interfering RNA delivery in vitro and in vivo. Cancer Gene Ther. 12: 321-328.
41. Leng, Q., P. Scaria, J. Zhu, N. Ambulos, P. Campbell, and A. J. Mixson. 2005. Highly branched HK peptides are effective carriers of siRNA. J. Gene Med. 7: 977-986.
42. Hu-Lieskovan, S., J. D. Heidel, D. W. Bartlett, M. E. Davis, and T. J. Triche. 2005. Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing's sarcoma. Cancer Res. 65: 8984-8992.
43. Czauderna, F., M. Fechtner, S. Dames, H. Aygun, A. Klippel, G. J. Pronk, K. Giese, and J. Kaufmann. 2003. Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells. Nucleic Acids Res. 31: 2705-2716.
44. Jackson, A. L., S. R. Bartz, J. Schelter, S. V. Kobayashi, J. Burchard, M. Mao, B. Li, G. Cavet, and P. S. Linsley. 2003. Expression profiling reveals off-target gene regulation by RNAi. Nat. Biotechnol. 21: 635-637.
45. Sledz, C. A., M. Holko, M. J. de Veer, R. H. Silverman, and B. R. Williams. 2003. Activation of the interferon system by short-interfering RNAs. Nat. Cell. Biol. 5: 834-839.
46. Reid, T., R. Warren, and D. Kirn. 2002. Intravascular adenoviral agents in cancer patients: lessons from clinical trials. Cancer Gene Ther. 9: 979-986.
47. Soutschek, J., A. Akinc, B. Bramlage, K. Charisse, R. Constien, M. Donoghue, S. Elbashir, A. Geick, P. Hadwiger, J. Harborth, et al. 2004. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 432: 173-178.
48. Lorenz, C., P. Hadwiger, M. John, H. P. Vornlocher, and C. Unverzagt. 2004. Steroid and lipid conjugates of siRNAs to enhance cellular uptake and gene silencing in liver cells. Bioorg. Med. Chem. Lett. 14: 4975-4977.
49. Sanderson, C. J. 1992. Interleukin-5, eosinophils, and disease. Blood 79: 3101-3109.
50. Grunig, G., M. Warnock, A. E. Wakil, R. Venkayya, F. Brombacher, D. M. Rennick, D. Sheppard, M. Mohrs, D. D. Donaldson, R. M. Locksley, and D. B. Corry. 1998. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 282: 2261-2263.